Share:
Peer-Reviewed Publication
Thorax2023;78(5):442-450.May 1, 2023Randomized Controlled Trial

Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial.

Marc Spielmanns1,2, Rainer Gloeckl3,4, Inga Jarosch3,4, Daniela Leitl3,4, Tessa Schneeberger3,4, Tobias Boeselt5, Stephan Huber6, Pawandeep Kaur-Bollinger6, Bernhard Ulm7, Claudia Mueller6, Jonas Bjoerklund6, Sabine Spielmanns8, Wolfram Windisch2,9, Anna-Maria Pekacka-Egli8, Andreas Rembert Koczulla3,4
1Pulmonary Medicine, Zuercher RehaZentren Klinik Wald, Wald, Switzerland spielmanns@me.com.
2Faculty of Health, Department for Pulmonary Medicine, University Witten Herdecke, Witten, Germany.
3Pulmonary Rehabilitation, Philipps-Universität Marburg, Marburg, Germany.
4Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.
5Pulmonary Medicine, Philipps University Marburg Faculty of Medicine, Marburg, Germany.
6Kaia Health GmbH, Munich, Bavaria, Germany.
7Unabhaengige Statistische Beratungen Bernhard Ulm, Munich, Bavaria, Germany.
8Pulmonary Medicine, Zuercher RehaZentren Klinik Wald, Wald, Switzerland.
9Department of Pneumology, Cologne Merheim Hospital, Kliniken der Stadt Koeln, Koeln, Germany.

Abstract

BACKGROUND: Evidence suggests that patients with COPD struggle to maintain improved physical activity (PA) after completing pulmonary rehabilitation (PR). Smartphone applications (apps) providing a comprehensive training programme have conferred healthy benefits. This study was conducted to determine whether regular usage of an app maintains PA following PR. METHODS: Patients with stage II-IV COP…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.